Thursday - September 17, 2026

Category Archives: Science

NSCLC Clinical Trial Pipeline Shows Potential with Active Contributions from 100+ Key Companies | DelveInsight

DelveInsight’s “NSCLC Pipeline Insight 2025” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the NSCLC pipeline landscape. It covers the NSCLC pipeline drug profiles, including clinical and nonclinical stage products. It also covers the NSCLC pipeline … Continue reading →

Malignant Pleural Effusion Clinical Trial Pipeline Gains Momentum: 8+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Malignant Pleural Effusion Pipeline Insight” report provides comprehensive global coverage of pipeline therapies for Malignant Pleural Effusion across various stages of clinical development. The report offers an in-depth analysis of key trends, emerging therapies, and competitive landscape dynamics, highlighting … Continue reading →

Familial Chylomicronemia Syndrome Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Familial Chylomicronemia Syndrome Pipeline Insight” report provides comprehensive global coverage of pipeline therapies for Familial Chylomicronemia Syndrome across various stages of clinical development. The report offers an in-depth analysis of key trends, emerging therapies, and competitive landscape dynamics, highlighting … Continue reading →

What Are Tan Delta Test Acceptable Values for Electrical Insulation Quality Assurance?

The image is Wrindu Tan Delta Tester. Wrindu, a leading global manufacturer and supplier of high-precision electrical insulation testing equipment for OEM and wholesale markets, has released comprehensive expert guidance on Tan Delta test acceptable values and best practices—an essential … Continue reading →

B-Cell Lymphoma Treatment Pipeline Shows Strong Momentum as 295+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “B-cell Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape. It covers the B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Glioblastoma Clinical Trial Pipeline Accelerates as 200+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Glioblastoma Pipeline Insight, 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Glioblastoma pipeline landscape. It covers the Glioblastoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioblastoma pipeline therapeutics … Continue reading →

Gastric Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 200+ Key Companies | DelveInsight

DelveInsight’s “Gastric Cancer Pipeline Insight 2025” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in the Gastric Cancer pipeline landscape. It covers the Gastric Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Glioma Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the glioma pipeline landscape. It covers the Glioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Glioma therapeutics … Continue reading →

Hemophagocytic Lymphohistiocytosis Clinical Trial Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Hemophagocytic Lymphohistiocytosis Pipeline Insights 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Hemophagocytic Lymphohistiocytosis pipeline landscape. It covers the Hemophagocytic Lymphohistiocytosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →